American Well Corporation
NYSE:AMWLMedical - Healthcare Information Services
+$0.24 today
- Market cap
- $171.77M
- Beta
- 1.70
- P/E (TTM)
- -1.6
- EPS (TTM)
- -$5.30
Volume 0.06M
Average 0.07M
AMWL Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
American Well CorporationNYSE: AMWL
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization dips below year-ago levels
Q1 FY2026 depreciation & amortization of $7.66M fell 1.8% year over year, behind the +3.9% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 9.8% from the prior quarter. Over 3 fiscal years it compounded at +9.1% a year.
Context
- Depreciation & amortization amounted to 13.6% of revenue in FY2025, up 0.7 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -1.8% toward the trailing-twelve-month pace of +3.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 33.96M USD
- Year-over-year change
- +3.0%
- 4-year CAGR
- +20.5%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 33.96M | +3.0% |
| FY2024 | 2024-12-31 | 32.98M | +4.6% |
| FY2023 | 2023-12-31 | 31.51M | +20.4% |
| FY2022 | 2022-12-31 | 26.17M | +62.6% |
| FY2021 | 2021-12-31 | 16.09M | — |
Depreciation & Amortization vs competitors
How AMWL compares with its peers on the latest reported figures
- AMWL's LTM Mar 2026 depreciation & amortization of $33.82M is the highest of the 9 companies compared; the peer median is $1.07M.
- Its year-over-year change of +3.9% is the 4th highest of 9, against a peer median of +2.1%.
- Depreciation & amortization amounts to 14.2% of revenue for AMWL, versus a peer median of 25.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $33.82M | +3.9% | +9.1% | 14.2% | |
| LTM Mar 2026 | $2.69M | -30.3% | -32.6% | 6.0% | |
| LTM Mar 2026 | $1.74M | +3.4% | — | 44.2% | |
| LTM Mar 2026 | $1.34M | +0.8% | -2.9% | 705.3% | |
| LTM Mar 2026 | $1.12M | +22.5% | +35.7% | — | |
| LTM Mar 2026 | $1.02M | -43.2% | +26.8% | — | |
| LTM Mar 2026 | $645K | -25.8% | +27.3% | — | |
| LTM Jun 2026 | $637.19K | +134.2% | +33.2% | 5.2% | |
| LTM Mar 2026 | $158K | +4.6% | +29.7% | — | |
| Peer median (excluding AMWL) | $1.07M | +2.1% | +27.3% | 25.1% | |
Competitors are the stored peer set for AMWL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 252.79M | 277.19M | 259.05M | 254.36M | 249.33M |
| Cost of Revenue | 148.47M | 160.42M | 164.29M | 155.41M | 116.47M |
| Gross Profit | 104.32M | 116.77M | 94.76M | 98.95M | 132.86M |
| Gross Margin | 41.3% | 42.1% | 36.6% | 38.9% | 53.3% |
| Research & Development | 106.59M | 138.49M | 105.83M | 86.07M | 72.86M |
| Selling, General & Admin | 160.78M | 227.98M | 213.11M | 197.45M | 131.31M |
| Operating Expenses | 283.46M | 392.62M | 786.9M | 316.49M | 238.13M |
| Depreciation & Amortization | 16.09M | 26.17M | 31.51M | 32.98M | 33.96M |
| EBITDA | (166.07M) | (245.84M) | (224.15M) | (176.91M) | (60.57M) |
| EBITDA Margin | -65.7% | -88.7% | -86.5% | -69.6% | -24.3% |
| Operating Income | (179.15M) | (275.85M) | (692.14M) | (217.53M) | (105.27M) |
| Operating Margin | -70.9% | -99.5% | -267.2% | -85.5% | -42.2% |
| Interest Income | 120K | 6.12M | 19.42M | 10.76M | 3.8M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (3.01M) | 3.85M | 16.83M | 7.65M | 10.74M |
| Income Before Tax | (182.16M) | (272.01M) | (675.31M) | (209.89M) | (94.53M) |
| Pre-Tax Margin | -72.1% | -98.1% | -260.7% | -82.5% | -37.9% |
| Income Tax Expense | (5.38M) | 64K | 3.86M | 2.75M | 434K |
| Net Income | (176.33M) | (270.43M) | (675.16M) | (208.14M) | (95.7M) |
| Net Margin | -69.8% | -97.6% | -260.6% | -81.8% | -38.4% |
| EPS (Basic) | (13.88) | (19.68) | (47.50) | (13.88) | (5.96) |
| EPS (Diluted) | (13.88) | (19.68) | (47.50) | (13.88) | (5.96) |
| Weighted Avg Shares | 12.7M | 13.71M | 14.21M | 15M | 16.05M |
| Weighted Avg Shares (Diluted) | 12.7M | 13.71M | 14.21M | 15M | 16.05M |
American Well Corporation
NYSE:AMWL
Intrinsic Alpha fair value
Locked
Current Price
$11.03
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.